Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Silver

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Blood|January 29, 2016
Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesGregory H Jones, Michael A Carrier, Richard T Silver, et al.
Cancer Genetics and Cytogenetics|October 24, 2002
Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemiaMartin L Lesser, Gordon W Dewald, Cristina P Sison, et al.
Experimental Hematology|August 7, 2003
The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylateEric Feldman, Vesna Najfeld, Michael Schuster, et al.
Blood|August 1, 2013
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysisRichard T Silver, William Chow, Attilio Orazi, et al.
American Journal of Clinical Pathology|February 6, 2007
Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosisEllinor I Peerschke, Richard T Silver, Babette B Weksler, et al.
British Journal of Haematology|October 6, 2004
Ex vivo evaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and plate(let) analyzer: effect of platelet antagonistsEllinor I B Peerschke, Richard T Silver, Babette Weksler, et al.
Molecular Cancer Research : MCR|January 31, 2003
Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cellsAnnabel Strife, David Wisniewski, Chongyuan Liu, et al.
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disordersQiaofang Chen, Pin Lu, Amy V Jones, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2013
Ruxolitinib for myelofibrosis--an update of its clinical effectsHagop M Kantarjian, Richard T Silver, Rami S Komrokji, et al.
Leukemia Research|October 11, 2011
Treatment of polycythemia vera with imatinib mesylateRichard T Silver, Michael H Bourla, Katherine Vandris, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Blood|January 29, 2016
Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesGregory H Jones, Michael A Carrier, Richard T Silver, et al.
Cancer Genetics and Cytogenetics|October 24, 2002
Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemiaMartin L Lesser, Gordon W Dewald, Cristina P Sison, et al.
Experimental Hematology|August 7, 2003
The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylateEric Feldman, Vesna Najfeld, Michael Schuster, et al.
Blood|August 1, 2013
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysisRichard T Silver, William Chow, Attilio Orazi, et al.
American Journal of Clinical Pathology|February 6, 2007
Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosisEllinor I Peerschke, Richard T Silver, Babette B Weksler, et al.
British Journal of Haematology|October 6, 2004
Ex vivo evaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and plate(let) analyzer: effect of platelet antagonistsEllinor I B Peerschke, Richard T Silver, Babette Weksler, et al.
Molecular Cancer Research : MCR|January 31, 2003
Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cellsAnnabel Strife, David Wisniewski, Chongyuan Liu, et al.
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disordersQiaofang Chen, Pin Lu, Amy V Jones, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2013
Ruxolitinib for myelofibrosis--an update of its clinical effectsHagop M Kantarjian, Richard T Silver, Rami S Komrokji, et al.
Leukemia Research|October 11, 2011
Treatment of polycythemia vera with imatinib mesylateRichard T Silver, Michael H Bourla, Katherine Vandris, et al.
Pageof 9